NCT02015117 2026-04-13Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain MetastasesNational Cancer Institute (NCI)Phase 1 Active not recruiting10 enrolled
NCT02910700 2025-12-17Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV MelanomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting52 enrolled